Pekka Vartiainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pekka Vartiainen has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Ganna
University of Helsinki
9 shared publications Finn Gen
6 shared publicationsMarkus Perola
6 shared publications- Aoxing Liu
Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
5 shared publications - Sakari Jukarainen
Faculty of Medicine, University of Helsinki, Helsinki, Finland
5 shared publications Tarja Heiskanen
Division of Pain Medicine Department of Anaesthesiology, Intensive Care, and Pain Medicine Helsinki University Hospital and University of Helsinki Helsinki Finland
4 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 70
Infant respiratory syncytial virus and childhood asthma: a nationwide registry-based, sibling-controlled, and genome-wide association study
- 7 September 2026
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 70
Open AccessInfant respiratory syncytial virus and childhood asthma: a nationwide registry-based, sibling-controlled, and genome-wide association study
- Open Access
Infant respiratory syncytial virus and childhood asthma: a nationwide registry-based, sibling-controlled, and genome-wide association study
Background: Early-life respiratory syncytial virus (RSV) infection is associated with childhood recurrent wheeze or asthma (RW/A), but causality and shared genetic liability remain unclear. Methods: We combined Finnish nationwide registries and Nordic genetic cohorts. First, in 965 312 Finnish children born between 1998 and 2014, we defined severe RSV as RSV hospitalisation before age 1 year, and recurrent wheezing or asthma (RW/A) as inhaled medication reimbursement between ages 1 and 7 years, and compared medication and eosinophil trajectories by RSV history. Second, we assessed familial confounding in 527 776 full siblings and 15 667 RW/A- discordant pairs. Third, we performed a genome-wide association study (GWAS) of RSV susceptibility with meta-analysis across six Nordic cohorts (3 107 cases, 92 091 controls) and two-sample Mendelian randomisation (2SMR) using 155 asthma-associated variants. Findings: RSV-associated RW/A showed higher inhaled medication use at ages 1–2 years but lower use after age 5, and lower mean blood eosinophils (0·341 vs 0·398×10□/L; p=0·008) than RW/A without RSV hospitalisation. In RW/A-discordant sibling pairs, RSV hospitalisation was associated with RW/A (OR 2·8; 95% CI 2·4–3·2), while unaffected siblings also had elevated RW/A prevalence. GWAS identified an RSV association at APBB1IP (rs787036; β=0·209; p=8·80×10 - □). 2SMR provided no evidence that asthma genetic liability influenced RSV susceptibility. Interpretation: The RSV–asthma association is unlikely to be explained by shared genetic or environmental factors, and RSV-associated RW/A shows a distinct trajectory. These findings help prioritise long-term outcomes for RSV prevention trials and monitoring. Funding: Päivikki and Sakari Sohlberg Foundation, Foundation for Pediatric Research, Sigrid Jusélius Foundation, Orion Research Foundation, the Research Council of Norway.
Open AccessInfant respiratory syncytial virus and childhood asthma: a nationwide registry-based, sibling-controlled, and genome-wide association study
Background: Early-life respiratory syncytial virus (RSV) infection is associated with childhood recurrent wheeze or asthma (RW/A), but causality and shared genetic liability remain unclear. Methods: We combined Finnish nationwide registries and Nordic genetic cohorts. First, in 965 312 Finnish children born between 1998 and 2014, we defined severe RSV as RSV hospitalisation before age 1 year, and recurrent wheezing or asthma (RW/A) as inhaled medication reimbursement between ages 1 and 7 years, and compared medication and eosinophil trajectories by RSV history. Second, we assessed familial confounding in 527 776 full siblings and 15 667 RW/A- discordant pairs. Third, we performed a genome-wide association study (GWAS) of RSV susceptibility with meta-analysis across six Nordic cohorts (3 107 cases, 92 091 controls) and two-sample Mendelian randomisation (2SMR) using 155 asthma-associated variants. Findings: RSV-associated RW/A showed higher inhaled medication use at ages 1–2 years but lower use after age 5, and lower mean blood eosinophils (0·341 vs 0·398×10□/L; p=0·008) than RW/A without RSV hospitalisation. In RW/A-discordant sibling pairs, RSV hospitalisation was associated with RW/A (OR 2·8; 95% CI 2·4–3·2), while unaffected siblings also had elevated RW/A prevalence. GWAS identified an RSV association at APBB1IP (rs787036; β=0·209; p=8·80×10 - □). 2SMR provided no evidence that asthma genetic liability influenced RSV susceptibility. Interpretation: The RSV–asthma association is unlikely to be explained by shared genetic or environmental factors, and RSV-associated RW/A shows a distinct trajectory. These findings help prioritise long-term outcomes for RSV prevention trials and monitoring. Funding: Päivikki and Sakari Sohlberg Foundation, Foundation for Pediatric Research, Sigrid Jusélius Foundation, Orion Research Foundation, the Research Council of Norway.
- Open Access
Sectoral Differences in Pediatric Antibiotic Prescribing for Acute Otitis Media
Importance: Acute otitis media is the most common infection in children and a major reason for antibiotic prescriptions, up to one third of which may be unnecessary. Sector of care may influence AOM management through differences in access to care, specialist involvement, parental expectations and financial foundation. Objective: The objective is to examine differences in antibiotic prescribing practices between healthcare sectors. Design: This is a nationwide register-based study comparing data from different healthcare sectors. Setting: Finnish primary and secondary healthcare, covering both public- and private-sector visits. Prescriptions and sociodemographic information were linked from nationwide registers. Participants: We included children under 18 years old who received a diagnosis of acute otitis media, defined by ICD-10 codes H65–H67, between January 1, 2017 and December 31, 2022. Exposures: The exposure is the sector of care (public sector vs. private sector). Main Outcomes and Measures: Primary outcomes were antibiotic prescribing, guideline adherence of the prescribed antibiotics, and rates of management failure. Secondary outcomes included antibiotic selection and guideline-adherent eligibility for tympanostomy tube placement. Associations were estimated using adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: The study included 295 064 children with 596 634 acute otitis media index visits, of which 77.6% resulted in an antibiotic prescription. Private-sector visits were associated with higher odds of antibiotic being prescribed (adjusted odds ratio [aOR]: 1.45; 95% CI: 1.41–1.49). Overall, 87.3% of antibiotic prescriptions were guideline adherent, but private-sector care was associated with lower odds of guideline-adherent prescribing (aOR: 0.64; 95% CI: 0.60–0.69). Compared with amoxicillin, the private sector showed higher odds of prescribing amoxicillin–clavulanic acid (32.8% vs. 8.3%; aOR: 3.00; 95% CI: 2.91–3.10). Management failure occurred in 7.0% of episodes and was more common in the private sector (aOR:1.52; 95% CI: 1.48–1.56). Only 48.7% of all tympanostomy tube insertions met the eligibility criteria. Conclusions and Relevance: In this study overall adherence to guideline-recommended antibiotic treatment for AOM was high in Finland. Nevertheless, observed clinically meaningful sectoral differences in antibiotic selection, treatment failure, and tympanostomy eligibility adherence indicate a need for targeted antimicrobial stewardship and quality-improvement efforts, especially in the private sector. Key Points: Question: Does the healthcare sector of care influence the management of acute otitis media? Findings: In this nationwide, episode-based register study of 295 064 Finnish children with acute otitis media, overall adherence to guideline-recommended antibiotic therapy was high. However, compared with the public sector, private-sector care was associated with higher odds of antibiotics being prescribed, lower guideline adherence and higher rates of management failure. Meaning: Sectoral differences in care suggest opportunities to improve guideline adherence, antimicrobial stewardship, and quality of care particularly in private sector.
Open AccessSectoral Differences in Pediatric Antibiotic Prescribing for Acute Otitis Media
Importance: Acute otitis media is the most common infection in children and a major reason for antibiotic prescriptions, up to one third of which may be unnecessary. Sector of care may influence AOM management through differences in access to care, specialist involvement, parental expectations and financial foundation. Objective: The objective is to examine differences in antibiotic prescribing practices between healthcare sectors. Design: This is a nationwide register-based study comparing data from different healthcare sectors. Setting: Finnish primary and secondary healthcare, covering both public- and private-sector visits. Prescriptions and sociodemographic information were linked from nationwide registers. Participants: We included children under 18 years old who received a diagnosis of acute otitis media, defined by ICD-10 codes H65–H67, between January 1, 2017 and December 31, 2022. Exposures: The exposure is the sector of care (public sector vs. private sector). Main Outcomes and Measures: Primary outcomes were antibiotic prescribing, guideline adherence of the prescribed antibiotics, and rates of management failure. Secondary outcomes included antibiotic selection and guideline-adherent eligibility for tympanostomy tube placement. Associations were estimated using adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: The study included 295 064 children with 596 634 acute otitis media index visits, of which 77.6% resulted in an antibiotic prescription. Private-sector visits were associated with higher odds of antibiotic being prescribed (adjusted odds ratio [aOR]: 1.45; 95% CI: 1.41–1.49). Overall, 87.3% of antibiotic prescriptions were guideline adherent, but private-sector care was associated with lower odds of guideline-adherent prescribing (aOR: 0.64; 95% CI: 0.60–0.69). Compared with amoxicillin, the private sector showed higher odds of prescribing amoxicillin–clavulanic acid (32.8% vs. 8.3%; aOR: 3.00; 95% CI: 2.91–3.10). Management failure occurred in 7.0% of episodes and was more common in the private sector (aOR:1.52; 95% CI: 1.48–1.56). Only 48.7% of all tympanostomy tube insertions met the eligibility criteria. Conclusions and Relevance: In this study overall adherence to guideline-recommended antibiotic treatment for AOM was high in Finland. Nevertheless, observed clinically meaningful sectoral differences in antibiotic selection, treatment failure, and tympanostomy eligibility adherence indicate a need for targeted antimicrobial stewardship and quality-improvement efforts, especially in the private sector. Key Points: Question: Does the healthcare sector of care influence the management of acute otitis media? Findings: In this nationwide, episode-based register study of 295 064 Finnish children with acute otitis media, overall adherence to guideline-recommended antibiotic therapy was high. However, compared with the public sector, private-sector care was associated with higher odds of antibiotics being prescribed, lower guideline adherence and higher rates of management failure. Meaning: Sectoral differences in care suggest opportunities to improve guideline adherence, antimicrobial stewardship, and quality of care particularly in private sector.
- Open Access
- 10 December 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (5) , e169-e171
Why Are Some Children More Sick Than Others? Lessons From Genome-wide Association Studies of Respiratory Viral Infections
- 10 December 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (5) , e169-e171
Open AccessWhy Are Some Children More Sick Than Others? Lessons From Genome-wide Association Studies of Respiratory Viral Infections
- Open Access
- 27 June 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (8) , 2074
Author Correction: Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design
- 27 June 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (8) , 2074
Open AccessAuthor Correction: Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design
- Open Access
- 18 June 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (7) , 1620-1627
Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design
Randomized controlled trials (RCTs) remain the gold standard for evaluating medical interventions, yet ethical, practical and financial constraints often necessitate reliance on observational data and trial emulations. This study explores how integrating genetic data can enhance both emulated and traditional trial designs. Using FinnGen (n = 425,483), we emulated four major cardiometabolic RCTs and showed how reduced differences in polygenic scores (PGS) between trial arms track improvement in study design. Simulation studies reveal that PGS alone cannot fully adjust for unmeasured confounding. Instead, Mendelian randomization analyses can be used to detect likely confounders. Finally, trial emulations provide a platform to assess and refine PGS implementation for genetic enrichment strategies. By comparing associations of PGS with trial outcomes in the general population and emulated trial cohorts, we highlight the need to validate prognostic enrichment approaches in trial-relevant populations. These results highlight the growing potential of incorporating genetic information to optimize clinical trial design.
- 18 June 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (7) , 1620-1627
Open AccessIncorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design
Randomized controlled trials (RCTs) remain the gold standard for evaluating medical interventions, yet ethical, practical and financial constraints often necessitate reliance on observational data and trial emulations. This study explores how integrating genetic data can enhance both emulated and traditional trial designs. Using FinnGen (n = 425,483), we emulated four major cardiometabolic RCTs and showed how reduced differences in polygenic scores (PGS) between trial arms track improvement in study design. Simulation studies reveal that PGS alone cannot fully adjust for unmeasured confounding. Instead, Mendelian randomization analyses can be used to detect likely confounders. Finally, trial emulations provide a platform to assess and refine PGS implementation for genetic enrichment strategies. By comparing associations of PGS with trial outcomes in the general population and emulated trial cohorts, we highlight the need to validate prognostic enrichment approaches in trial-relevant populations. These results highlight the growing potential of incorporating genetic information to optimize clinical trial design.
- Open Access
- 23 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Socio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classes
Low drug adherence is a major obstacle to the benefits of pharmacotherapies and it is therefore important to identify factors associated with discontinuing or being poorly adherent to a prescribed treatment regimen. Using high-quality nationwide health registry data and genome-wide genotyping, we evaluate the impact of socio-demographic and genetic risk factors on adherence and persistence for 5 common medication classes that require long-term, regular therapy (N = 1,814,591 individuals from Finnish nationwide registries, 217,005 with genetic data from Finland and Estonia). Need for social assistance and immigration status show a notable negative effect on persistence and adherence across the examined medications (odd ratios between 0.48 and 0.82 for persistence and between 1.1% to 4.3% decrease in adherence) while demographic and health factors show comparably modest or inconsistent effects. A genome-wide scan does not identify genetic variants associated with the two phenotypes, while some pharmacogenes (i.e. CYP2C9 and SLCO1B1) are modestly associated with persistence, but not with adherence. We observe significant genetic correlations between medication adherence and participation in research studies. Overall, our findings suggest that socio-economically disadvantaged groups would benefit from targeted interventions to improve the dispensing and uptake of pharmacological treatments.
- 23 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-13
Open AccessSocio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classes
Low drug adherence is a major obstacle to the benefits of pharmacotherapies and it is therefore important to identify factors associated with discontinuing or being poorly adherent to a prescribed treatment regimen. Using high-quality nationwide health registry data and genome-wide genotyping, we evaluate the impact of socio-demographic and genetic risk factors on adherence and persistence for 5 common medication classes that require long-term, regular therapy (N = 1,814,591 individuals from Finnish nationwide registries, 217,005 with genetic data from Finland and Estonia). Need for social assistance and immigration status show a notable negative effect on persistence and adherence across the examined medications (odd ratios between 0.48 and 0.82 for persistence and between 1.1% to 4.3% decrease in adherence) while demographic and health factors show comparably modest or inconsistent effects. A genome-wide scan does not identify genetic variants associated with the two phenotypes, while some pharmacogenes (i.e. CYP2C9 and SLCO1B1) are modestly associated with persistence, but not with adherence. We observe significant genetic correlations between medication adherence and participation in research studies. Overall, our findings suggest that socio-economically disadvantaged groups would benefit from targeted interventions to improve the dispensing and uptake of pharmacological treatments.
- Open Access
Effects of parental autoimmune diseases on type 1 diabetes in offspring can be partially explained by HLA and non-HLA polymorphisms
SUMMARY: Type 1 diabetes (T1D) and other autoimmune diseases (AIDs) often co-occur in families. Leveraging data from 58,284 family trios in Finnish nationwide registers (FinRegistry), we identified that, out of 50 parental AIDs examined, 15 were associated with an increased T1D risk in offspring. These identified epidemiological associations were further assessed in 470K genotyped Finns from FinnGen study through comprehensive genetic analyses, partitioned into HLA and non-HLA variations. Using FinnGen’s 12,563 trios, a within-family polygenic transmission analysis demonstrated that the aggregation of many parental AIDs with offspring T1D can be partially explained by HLA and non-HLA polymorphisms in a disease-dependent manner. We, therefore, proposed a parental polygenic score (PGS), incorporating both HLA and non-HLA polymorphisms, to characterize the cumulative risk pattern of T1D in offspring. This raises an intriguing possibility of using parental PGS, in conjunction with clinical diagnoses, to inform individuals about T1D risk in their offspring.
Open AccessEffects of parental autoimmune diseases on type 1 diabetes in offspring can be partially explained by HLA and non-HLA polymorphisms
SUMMARY: Type 1 diabetes (T1D) and other autoimmune diseases (AIDs) often co-occur in families. Leveraging data from 58,284 family trios in Finnish nationwide registers (FinRegistry), we identified that, out of 50 parental AIDs examined, 15 were associated with an increased T1D risk in offspring. These identified epidemiological associations were further assessed in 470K genotyped Finns from FinnGen study through comprehensive genetic analyses, partitioned into HLA and non-HLA variations. Using FinnGen’s 12,563 trios, a within-family polygenic transmission analysis demonstrated that the aggregation of many parental AIDs with offspring T1D can be partially explained by HLA and non-HLA polymorphisms in a disease-dependent manner. We, therefore, proposed a parental polygenic score (PGS), incorporating both HLA and non-HLA polymorphisms, to characterize the cumulative risk pattern of T1D in offspring. This raises an intriguing possibility of using parental PGS, in conjunction with clinical diagnoses, to inform individuals about T1D risk in their offspring.
- Top Cited PapersOpen Access
- 18 December 2023
- Published by Springer Nature in Nature Human Behaviour
- Vol. 8 (2) , 276-287
Evidence from Finland and Sweden on the relationship between early-life diseases and lifetime childlessness in men and women
The percentage of people without children over their lifetime is approximately 25% in men and 20% in women. Individual diseases have been linked to childlessness, mostly in women, yet we lack a comprehensive picture of the effect of early-life diseases on lifetime childlessness. We examined all individuals born in 1956–1968 (men) and 1956–1973 (women) in Finland (n = 1,035,928) and Sweden (n = 1,509,092) to the completion of their reproductive lifespan in 2018. Leveraging nationwide registers, we associated sociodemographic and reproductive information with 414 diseases across 16 categories, using a population and matched-pair case–control design of siblings discordant for childlessness (71,524 full sisters and 77,622 full brothers). The strongest associations were mental–behavioural disorders (particularly among men), congenital anomalies and endocrine–nutritional–metabolic disorders (strongest among women). We identified new associations for inflammatory and autoimmune diseases. Associations were dependent on age at onset and mediated by singlehood and education. This evidence can be used to understand how disease contributes to involuntary childlessness.
- 18 December 2023
- Published by Springer Nature in Nature Human Behaviour
- Vol. 8 (2) , 276-287
Top Cited PapersOpen AccessEvidence from Finland and Sweden on the relationship between early-life diseases and lifetime childlessness in men and women
The percentage of people without children over their lifetime is approximately 25% in men and 20% in women. Individual diseases have been linked to childlessness, mostly in women, yet we lack a comprehensive picture of the effect of early-life diseases on lifetime childlessness. We examined all individuals born in 1956–1968 (men) and 1956–1973 (women) in Finland (n = 1,035,928) and Sweden (n = 1,509,092) to the completion of their reproductive lifespan in 2018. Leveraging nationwide registers, we associated sociodemographic and reproductive information with 414 diseases across 16 categories, using a population and matched-pair case–control design of siblings discordant for childlessness (71,524 full sisters and 77,622 full brothers). The strongest associations were mental–behavioural disorders (particularly among men), congenital anomalies and endocrine–nutritional–metabolic disorders (strongest among women). We identified new associations for inflammatory and autoimmune diseases. Associations were dependent on age at onset and mediated by singlehood and education. This evidence can be used to understand how disease contributes to involuntary childlessness.
- Open Access
- 25 October 2023
- Published by Elsevier in The Lancet Digital Health
- Vol. 5 (11) , e821-e830
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
- 25 October 2023
- Published by Elsevier in The Lancet Digital Health
- Vol. 5 (11) , e821-e830
Open AccessRisk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model